Carmustine Kit
Product Images NDC 0781-3474

12 FDA label images from Sandoz Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 0781-3474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Figure 1)

Structure (Figure 1)
Chemical structure of Carmustine, showing its molecular composition including chlorine (Cl), nitrogen (N), carbon (C), oxygen (O), and hydrogen (H) atoms arranged in the known configuration for this active pharmaceutical ingredient.*
FDA Label Image

Diluent (Figure 10)

Diluent (Figure 10)
Label for Dehydrated Alcohol Injection, USP, 3 mL sterile diluent for Carmustine Injection, USP. The label includes storage instructions to refrigerate between 2° to 8°C (36° to 46°F), manufacturer information (Jiangsu Hengrui Pharmaceuticals Co., Ltd., China) for Sandoz Inc., Princeton, NJ, and displays a barcode with a space for lot number and expiration date.*
FDA Label Image

Powder (Figure 11)

Powder (Figure 11)
Carmustine for Injection, USP 100 mg per vial kit label by Sandoz Inc. The label highlights that it is for intravenous infusion after reconstitution, is a cytotoxic agent for single-dose use, and must be refrigerated immediately. It includes handling instructions, storage conditions, and manufacturer details for Jiangsu Hengrui Pharmaceuticals, China, marketed by Sandoz Inc.*
FDA Label Image

Carton (Figure 12)

Carton (Figure 12)
Packaging label for Carmustine for Injection, USP 100 mg per vial, a kit including 1 vial of Carmustine and 1 vial of sterile diluent for injection. The label highlights intravenous infusion after reconstitution, refrigeration requirements, and that it is a single-dose vial. Manufactured by Jiangsu Hengrui Pharmaceuticals for Sandoz Inc., Princeton, NJ. The label includes handling instructions and storage conditions.*
FDA Label Image

Step 1 (Figure 2)

Step 1 (Figure 2)
Carmustine for Injection, USP 100 mg/vial in a kit packaging by Sandoz Inc. The kit includes a vial of Carmustine and a vial of Dehydrated Alcohol Injection, USP 3 mL, labeled as a combikit of product and diluent.*
FDA Label Image

Step 2 (Figure 3)

Step 2 (Figure 3)
An instructional diagram showing a hand holding a vial labeled 'Carmustine for Injection, USP 100 mg/vial' alongside a smaller vial labeled 'Dehydrated Alcohol Injection, USP 3 mL.' The illustration is titled 'COMBIKIT OF PRODUCT & DILUENT,' depicting components of the Carmustine kit by Sandoz Inc.*
FDA Label Image

Step 3 (Figure 4)

Step 3 (Figure 4)
Illustration showing the combination of two solution vials labeled 'Carmustine for Injection, USP 100 mg/vial' and 'Diluted Alcohol Injection, USP 3 mL.' The image depicts mixing the two components using a syringe to prepare the Carmustine kit product.*
FDA Label Image

Step 4 (Figure 5)

Step 4 (Figure 5)
Illustration showing a Carmustine for Injection, USP 100 mg vial along with a 3 mL vial of Dehydrated Alcohol Injection, USP, labeled as a combikit of product and diluent with a syringe extracting liquid from the Carmustine vial.*
FDA Label Image

Step 5 (Figure 6)

Step 5 (Figure 6)
Carmustine for Injection, USP 100 mg/vial kit by Sandoz Inc., containing two vials: one labeled 'Carmustine for Injection, USP' and the other 'Dehydrated Alcohol Injection, USP 3 mL,' with the kit marked as containing both product and diluent.*
FDA Label Image

Step 6 (Figure 7)

Step 6 (Figure 7)
Illustration showing a preparation kit for Carmustine injection. The kit includes a vial labeled 'Carmustine for Injection, USP 100 mg/vial' and a smaller vial labeled 'Dehydrated Alcohol Injection, USP 3 mL.' A syringe is shown drawing liquid from one of the vials. The kit is labeled 'COMBIKIT OF PRODUCT & DILUENT.'*
FDA Label Image

Step 7 (Figure 8)

Step 7 (Figure 8)
Carmustine for Injection, USP 100 mg/vial kit including a vial of Carmustine and a 3 mL vial of Dehydrated Alcohol Injection, USP as diluent, shown in a divided container labeled COMBIKIT OF PRODUCT & DILUENT.*
FDA Label Image

Step 8 (Figure 9)

Step 8 (Figure 9)
Illustration of a CARMUSTINE kit for injection, showing a vial labeled 'Carmustine for Injection, USP 100 mg/vial' connected to a syringe, alongside a smaller diluent vial labeled 'Diluent for Injection, USP 3 mL.' The kit is presented in an open box with the text 'COMBIMIXT OF PRODUCT & DILUENT' visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.